Qube Research & Technologies (QRT)
AGRX

Qube Research & Technologies (QRT)’s Agile Therapeutics AGRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6
Closed -$11K – 3121
2021
Q3 		$11K Hold
6
– – ﹤0.01% 2035
2021
Q2 		$16K Buy
+6
New +$19.8K ﹤0.01% 2115
2020
Q3 		– Sell
-28
Closed -$158K – 2217
2020
Q2 		$158K Sell
28
-17
-38% -$88.3K ﹤0.01% 1459
2020
Q1 		$166K Sell
45
-61
-58% -$350K 0.01% 904
2019
Q4 		$529K Buy
+106
New +$370K 0.02% 921

Other funds holding AGRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AGRX Position: Q4 2021 in Review

Qube Research & Technologies (QRT) sold out of Agile Therapeutics (AGRX) in Q4 2021, closing a stake of 6 shares — an estimated $11K sold.

Qube Research & Technologies (QRT) first reported a position in AGRX in Q4 2019 and held it in 5 quarters. The position peaked at $529K in Q4 2019. 45 funds tracked by Wall St. Rank hold AGRX as of Q4 2021.

  • Qube Research & Technologies (QRT) reported no remaining Agile Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 6 Agile Therapeutics shares in Q4 2021, an estimated $11K.
  • Qube Research & Technologies (QRT) first reported a position in Agile Therapeutics in Q4 2019 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Agile Therapeutics position peaked at $529K in Q4 2019.
  • 45 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2021, filed 1 Feb 2022.